Literature DB >> 4773654

[Letter: Secondary but reversible effects of perhexilin administration].

A Abaza, D Cattan, C Aziza, E Pappo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4773654

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


× No keyword cloud information.
  8 in total

1.  Polyneuropathy after perhexiline maleate therapy.

Authors:  F Lhermitte; M Fardeau; F Chedru; J Mallecourt
Journal:  Br Med J       Date:  1976-05-22

2.  [Electron microscopic study of nerve, muscle and skin lesions induced by perhexiline maleate (author's transl)].

Authors:  J M Mussini; J J Hauw; R Escourolle
Journal:  Acta Neuropathol       Date:  1977-04-29       Impact factor: 17.088

Review 3.  Adverse reactions to calcium antagonists.

Authors:  J G Lewis
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

4.  Perhexiline maleate toxicity on human liver cell lines.

Authors:  J Y Le Gall; A Guillouzo; D Glaise; Y Deugnier; M Messner; M Bourel
Journal:  Gut       Date:  1980-11       Impact factor: 23.059

5.  Comparative trial of perhexiline maleate and oxprenolol in patients with angina pectoris.

Authors:  J Pilcher
Journal:  Postgrad Med J       Date:  1978-10       Impact factor: 2.401

6.  Liver damage associated with perhexiline maleate.

Authors:  D Lewis; H C Wainwright; M C Kew; S Zwi; C Isaacson
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

7.  Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith; J D Lockhart
Journal:  Br Med J (Clin Res Ed)       Date:  1982-01-30

8.  Impaired oxidation of debrisoquine in patients with perhexiline liver injury.

Authors:  M Y Morgan; R Reshef; R R Shah; N S Oates; R L Smith; S Sherlock
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.